Announcements Trials
Browse Landscape

Phase

Phase 1 1

Status

Recruiting 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Thoracic 1Other solid neoplasm 1Gastrointestinal 1

Conditions

Recurrence 2Pancreatic Neoplasms 2Neoplasms 1Mesothelioma 1Lung Neoplasms 1Liver Neoplasms 1Hematologic Neoplasms 1Head and Neck Neoplasms 1Gynecological Solid Tumors 1

Interventions

Carboplatin 5Nivolumab 4pembrolizumab 3Pemetrexed 3Ipilimumab 3fludarabine 2atezolizumab 2Cyclophosphamide 2Cisplatin 2tremelimumab 1sotorasib 1osimertinib 1olaparib 1durvalumab 1Tumor Burden 1Thoracoscopy 1Tablets 1Saline Solution 1Quality of Life 1Observation 1Magnesium Sulfate 1Injections 1Influenza Vaccines 1Histocompatibility Testing 1Gemcitabine 1Fluorodeoxyglucose F18 1Exercise Therapy 1Combined Modality Therapy 1Cell- and Tissue-Based Therapy 1Blood Specimen Collection 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Recruiting × Mesothelioma × Cell- and Tissue-Based Therapy × Clear all
NCT06196294 2024-06-26

GPC3/Mesothelin-CAR-γδT Cells Against Cancers

Second Affiliated Hospital of Guangzhou Medical University

Phase 1 Recruiting
30 enrolled
GastrointestinalOther solid neoplasmThoracic

Liver Neoplasms, Lung Neoplasms, Mesothelioma, Pancreatic Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon âš¡